Latest Stock Market News

However, 8 smallcap stocks achieved significant weekly price increases between 15% and 37%

In this weekly rally, ETMarkets identified that 11 stocks from the BSE100 pack showed consistent price increases during this timeframe.

Investor hopes for a soft landing for the U.S. economy will be tested next week with the release of key labor market data. The S&P 500 index is up 20% year-to-date, driven by rate cuts and hopes of controlled inflation. The upcoming jobs report could influence future Federal Reserve decisions.

SEBI’s study highlights several important findings that shed light on emerging trading patterns in India. Some of these observations challenge common misconceptions and provide much-needed reality checks.

Power demand in India is expected to grow at a faster rate, with a 7% CAGR over the next decade, driven by a robust economic outlook, urbanization, and new demand drivers such as electric vehicles (EVs), data centres, and the electrification of energy needs.

Benchmark Sensex rose 1.22% in September, as many as 62 stocks on BSE 500 clocked double-digit gains of up to 35%. Among these, about seven of them offered over 25% returns to investors during the month.

Swedish fund EQT Partners is set to sell its five-year-old investment in US-based healthcare IT services firm AGS Health, aiming for a valuation of $750 million-$780 million. The sale process, managed by JP Morgan and Bank of America, will launch early next year. AGS Health provides revenue cycle management solutions and employs 12,000 people across multiple locations.

​​The regulator had undertaken a detailed investigation by certain entities from January 1,2021 to October 31,2022, who were consistently placing orders ahead of the big clients including Bharat Kanaiyalal Sheth Family Trust in the cash segment and were squaring off the same.

​​Europacific Growth Fund, Greater India Portfolio, Capri Global Holdings and Morgan Stanley Asia Singapore Pte were among the buyers in the deal. Shares of Nuvama Wealth Management rose 0.99% to close at Rs 6,837.15 on Friday.

In a stock exchange filing, Sequent Scientific said its board has approved a proposal to merge Viyash Life Sciences and its group companies, and its wholly owned subsidiary Sequent Research with it.